Intelligent Bio Solutions, Inc. (INBS)
1.52
-0.01
(-0.65%)
USD |
NASDAQ |
Oct 12, 13:55
Intelligent Bio Solutions Net Income (Quarterly) : -3.917M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.917M |
| March 31, 2026 | -2.870M |
| December 31, 2025 | -2.687M |
| September 30, 2025 | -2.995M |
| June 30, 2025 | -3.103M |
| March 31, 2025 | -2.551M |
| December 31, 2024 | -2.257M |
| September 30, 2024 | -2.695M |
| June 30, 2024 | -2.795M |
| March 31, 2024 | -2.987M |
| December 31, 2023 | -1.976M |
| September 30, 2023 | -2.432M |
| June 30, 2023 | -2.671M |
| March 31, 2023 | -6.352M |
| December 31, 2022 | -0.4271M |
| September 30, 2022 | -1.214M |
| June 30, 2022 | -2.088M |
| Date | Value |
|---|---|
| March 31, 2022 | -1.344M |
| December 31, 2021 | -3.464M |
| September 30, 2021 | -1.438M |
| June 30, 2021 | -0.8502M |
| March 31, 2021 | -3.143M |
| December 31, 2020 | -1.990M |
| September 30, 2020 | -1.077M |
| June 30, 2020 | -0.464M |
| March 31, 2020 | -0.1111M |
| December 31, 2019 | -1.853M |
| September 30, 2019 | -0.7648M |
| June 30, 2019 | -3.185M |
| March 31, 2019 | -1.611M |
| December 31, 2018 | -1.321M |
| September 30, 2018 | |
| June 30, 2018 | -1.890M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Sanara MedTech, Inc. | -0.4111M |
| Anteris Technologies Global Corp. | -28.78M |
| 20/20 Biolabs, Inc. | -1.506M |
| Quest Diagnostics, Inc. | 333.00M |
| Labcorp Holdings, Inc. | 299.10M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.146M |
| Total Expenses (Quarterly) | 5.054M |
| EPS Diluted (Quarterly) | -1.345 |
| Enterprise Value | 2.052M |
| Gross Profit Margin (Quarterly) | 21.68% |
| Profit Margin (Quarterly) | -341.9% |
| Earnings Yield | -621.5% |
| Normalized Earnings Yield | -605.84 |